Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma

Zhi-He Liu,1 Lin Zhang,2 Fan-Jing Jing,1 Shu-Xin Xiao,1 Yan Gao,1 Hai-Yan Bian,1 Xia Zhao1 1Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of China; 2Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu ZH, Zhang L, Jing FJ, Xiao SX, Gao Y, Bian HY, Zhao X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/3f7a24b1e33542c5a25ec5a20086163f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f7a24b1e33542c5a25ec5a20086163f
record_format dspace
spelling oai:doaj.org-article:3f7a24b1e33542c5a25ec5a20086163f2021-12-02T19:37:59ZGenetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma1178-7031https://doaj.org/article/3f7a24b1e33542c5a25ec5a20086163f2021-11-01T00:00:00Zhttps://www.dovepress.com/genetic-polymorphisms-in-nlrp3-inflammasome-associated-genes-in-patien-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Zhi-He Liu,1 Lin Zhang,2 Fan-Jing Jing,1 Shu-Xin Xiao,1 Yan Gao,1 Hai-Yan Bian,1 Xia Zhao1 1Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of China; 2Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of ChinaCorrespondence: Xia ZhaoDepartment of Hematology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Shinan District, Qingdao, 266000, Shandong, People’s Republic of ChinaTel/Fax +8653282911201Email alice-xia@163.comPurpose: The role of NLRP3 inflammasome in the progression of many diseases has been increasingly recognized. However, the function of this molecular assembly in the development and progression of B-cell non-Hodgkin’s lymphoma remains unclear.Patients and Methods: In this study, we investigated the polymorphisms in the NLRP3 inflammasome associated genes in 281 patients with B-cell non-Hodgkin’s lymphoma and 385 age- and gender-matched healthy controls.Results: We found that IL-18 (rs1946518) and NFκB-94 ins/del (rs28362491) contributed to susceptibility to B-cell non-Hodgkin’s lymphoma. Specifically, the allele “G” in IL-18 (rs1946518) and allele “ins” in NFκB-94 ins/del (rs28362491) were significantly associated with the risk of disease. The AA genotype of CARD8 (rs2043211) and the higher level of serum lactate dehydrogenase (LDH) led to statistically poorer B-cell non-Hodgkin’s lymphoma survival. Less frequent genotype TT of CARD8 (rs2043211) was observed in patients with higher LDH level, clinical stages III–IV of disease, and IPI 3– 5, although the relationship did not reach statistical significance. However, IPI is an independent prognostic factor for B-cell non-Hodgkin’s lymphoma.Conclusion: IL-18 (rs1946518) and NFκB-94 ins/del (rs28362491) gene polymorphisms appear to be the factors influencing the risk of B-cell non-Hodgkin’s lymphoma. CARD8 (rs2043211) polymorphisms are important factors for the survival of patients with this disease.Keywords: NLRP3, inflammasome, B-cell non-Hodgkin’s lymphoma, susceptibility, survivalLiu ZHZhang LJing FJXiao SXGao YBian HYZhao XDove Medical Pressarticlenlrp3inflammasomeb-cell non-hodgkin’s lymphomasusceptibilitysurvivalPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 5687-5697 (2021)
institution DOAJ
collection DOAJ
language EN
topic nlrp3
inflammasome
b-cell non-hodgkin’s lymphoma
susceptibility
survival
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle nlrp3
inflammasome
b-cell non-hodgkin’s lymphoma
susceptibility
survival
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Liu ZH
Zhang L
Jing FJ
Xiao SX
Gao Y
Bian HY
Zhao X
Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
description Zhi-He Liu,1 Lin Zhang,2 Fan-Jing Jing,1 Shu-Xin Xiao,1 Yan Gao,1 Hai-Yan Bian,1 Xia Zhao1 1Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of China; 2Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of ChinaCorrespondence: Xia ZhaoDepartment of Hematology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Shinan District, Qingdao, 266000, Shandong, People’s Republic of ChinaTel/Fax +8653282911201Email alice-xia@163.comPurpose: The role of NLRP3 inflammasome in the progression of many diseases has been increasingly recognized. However, the function of this molecular assembly in the development and progression of B-cell non-Hodgkin’s lymphoma remains unclear.Patients and Methods: In this study, we investigated the polymorphisms in the NLRP3 inflammasome associated genes in 281 patients with B-cell non-Hodgkin’s lymphoma and 385 age- and gender-matched healthy controls.Results: We found that IL-18 (rs1946518) and NFκB-94 ins/del (rs28362491) contributed to susceptibility to B-cell non-Hodgkin’s lymphoma. Specifically, the allele “G” in IL-18 (rs1946518) and allele “ins” in NFκB-94 ins/del (rs28362491) were significantly associated with the risk of disease. The AA genotype of CARD8 (rs2043211) and the higher level of serum lactate dehydrogenase (LDH) led to statistically poorer B-cell non-Hodgkin’s lymphoma survival. Less frequent genotype TT of CARD8 (rs2043211) was observed in patients with higher LDH level, clinical stages III–IV of disease, and IPI 3– 5, although the relationship did not reach statistical significance. However, IPI is an independent prognostic factor for B-cell non-Hodgkin’s lymphoma.Conclusion: IL-18 (rs1946518) and NFκB-94 ins/del (rs28362491) gene polymorphisms appear to be the factors influencing the risk of B-cell non-Hodgkin’s lymphoma. CARD8 (rs2043211) polymorphisms are important factors for the survival of patients with this disease.Keywords: NLRP3, inflammasome, B-cell non-Hodgkin’s lymphoma, susceptibility, survival
format article
author Liu ZH
Zhang L
Jing FJ
Xiao SX
Gao Y
Bian HY
Zhao X
author_facet Liu ZH
Zhang L
Jing FJ
Xiao SX
Gao Y
Bian HY
Zhao X
author_sort Liu ZH
title Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
title_short Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
title_full Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
title_fullStr Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
title_full_unstemmed Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
title_sort genetic polymorphisms in nlrp3 inflammasome-associated genes in patients with b-cell non-hodgkin’s lymphoma
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/3f7a24b1e33542c5a25ec5a20086163f
work_keys_str_mv AT liuzh geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT zhangl geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT jingfj geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT xiaosx geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT gaoy geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT bianhy geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
AT zhaox geneticpolymorphismsinnlrp3inflammasomeassociatedgenesinpatientswithbcellnonhodgkinrsquoslymphoma
_version_ 1718376316748693504